Errata.Because the study "Threshold of Trichloroethylene trichloroethylene /tri·chlo·ro·eth·y·lene/ (-eth´i-len) a clear, mobile liquid used as an industrial solvent; formerly used as an inhalant anesthetic. tri·chlo·ro·eth·yl·ene n. Contamination in Maternal Drinking Waters drinking water supply of water available to animals for drinking supplied via nipples, in troughs, dams, ponds and larger natural water sources; an insufficient supply leads to dehydration; it can be the source of infection, e.g. leptospirosis, salmonellosis, or of poisoning, e.g. Affecting Fetal fetal /fe·tal/ (fe´tal) of or pertaining to a fetus or the period of its development. fe·tal adj. Of, relating to, or being a fetus. Heart Development in the Rat" (Johnson et al. 2003) was a long-term and continuous study, the authors compiled the data from controls of several treatment groups. The control "sets" were statistically analyzed an·a·lyze tr.v. an·a·lyzed, an·a·lyz·ing, an·a·lyz·es 1. To examine methodically by separating into parts and studying their interrelations. 2. Chemistry To make a chemical analysis of. 3. comparing the data to each other before being combined. The authors opine that the control values were statistically consistent across and throughout all the treatment groups. Using the control data in a cumulative manner increased the generalizability of the data, which purports to demonstrate the background rate and variability around rate estimates. The larger sample size somewhat increased statistical power without the inappropriate use of further valuable animal resources. Table 1 presents the date ranges of experimental treatment and the coinciding control treatments. Each treatment exposure had a corresponding control group. Also, because of the more detailed information on competing financial interests now included in EHP's Instructions to Authors, the authors now report that S.J. Goldberg served as an expert witness for a plaintiff in a judicial hearing in 1997. As previously stated in a prior letter to the editor (Johnson et al. 2004), at all times throughout this research, the authors were free to design, conduct, interpret, and publish the research without compromise by any controlling sponsor as a condition of review or publication. In "Environmental Health Disparities
Health disparities (also called health inequalities in some countries) refer to gaps in the quality of health and health care across racial, ethnic, and socioeconomic groups. : A Framework Integrating Psychosocial psychosocial /psy·cho·so·cial/ (si?ko-so´shul) pertaining to or involving both psychic and social aspects. psy·cho·so·cial adj. Involving aspects of both social and psychological behavior. and Environmental Concepts" by Gee et al. [Environ Health Perspect 112:1645-1653 (2004)], the title of Figure 1 should be "Stress-exposure disease framework for environmental health disparities." REFERENCES Johnson PD, Dawson BV, Goldberg SJ. 1998a. Cardiac teratogenicity ter·a·to·ge·nic·i·ty n. The capability of producing fetal malformation. teratogenicity, (terˈ· of trichloroethylene metabolites Metabolites Substances produced by metabolism or by a metabolic process. Mentioned in: Interactions . J Am Coll Cardiol 32(2):540-545. Johnson PD, Dawson BV, Goldberg SJ. 1998b. A review: trichloroethylene metabolites: potential cardiac teratogens teratogens, (t n.pl agents that cause congenital malformations and developmental abnormalities if introduced during gestation. . Environ Health Perspect 106(suppl 4):995-999. Johnson PD, Dawson BV, Goldberg SJ. MZ. 2004. Trichloroethylene: Johnson et al.'s Response [Letter]. Environ Health Perspect 112:A608-A609. Johnson PD, Goldberg SJ, Mays MZ, Dawson BV. 2003. Threshold of trichloroethylene contamination in maternal drinking waters affecting fetal heart development in the rat. Environ Health Perspect 111:289-292.
Table 1. Control versus TCE treatment groups and dates of exposure.
Control
Fetuses/mothers (a) Dates
135/15 14 Jun 1989-10 Oct 1992
155/13 11 Dec 1992-20 Oct 1993 (a)
62/6 15 Apr 1994-23 May 1994 (a)
120/10 6 Jul 1994-7 Jul 1995
134/11 18 Jul 1995-6 Oct 1995
TCE
Dose Fetuses/mothers Dates
1,100 ppm 105/9 29 Jun 1989-12 Mar 1990
1.5 ppm 181/13 29 Dec 1989-26 Dec 1990
2.5 ppb 144/12 6 Jun 1995-13 Jun 1995
250 ppb 110/9 5 Jul 1995-21 Jul 1995
(a) The total number of control rat fetuses/mothers was 606/55.
(b) Other studies that coincided with these control groups were
carried out during December 1989-June 1995 [e.g., metabolites that
were reported in other articles (Johnson et al. 1998a, 1998b).
|
|
||||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion